Li He
Lawyers
Filters
Zai Lab Limited $230 Million Follow-On Offering of American Depositary Shares
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of $230 million of American Depositary Shares representing 9,019,608 ordinary shares of the company. The ADSs…
UP Fintech Holding Limited Initial Public Offering and NASDAQ Listing
Davis Polk advised the representatives of the underwriters on the SEC-registered initial public offering by UP Fintech Holding Limited (Tiger Trade) of 13,000,000 American Depositary Shares…
Davis Polk Advises CStone Pharmaceuticals on Its HK$2.24 Billion (US$285.05 Million) Initial Public Offering
Davis Polk advised CStone Pharmaceuticals in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
AsiaInfo Technologies Limited HK$865.3 Million (US$110.6 Million) Initial Public Offering
Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S of…
Tencent Music Entertainment Group $1.1 billion IPO and NYSE listing
Davis Polk advised Tencent Music Entertainment Group on its SEC-registered initial public offering of 82,000,000 American Depositary Shares, consisting of 41,029,829 ADSs sold by Tencent…
MOGU Inc. Initial Public Offering and NYSE Listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by MOGU Inc. of 4,750,000 American Depositary Shares, each representing 25 Class A ordinary shares,…
Davis Polk Advises Tongcheng-Elong on Its HK$1.41 Billion (US$180 Million) Initial Public Offering
Davis Polk advised Tongcheng-Elong Holdings Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on…
Davis Polk Advises CNFinance Holdings Limited on Its Initial Public Offering and NYSE Listing
Davis Polk advised CNFinance Holdings Limited on its SEC-registered initial public offering of 6,925,000 American Depositary Shares, including the partial exercise of the underwriters’…
Innovent Biologics, Inc. HK$3.15 Billion (US$403.1 Million) Initial Public Offering
Davis Polk advised the underwriters and joint global coordinators in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on…
Davis Polk Advises X Financial on Its Initial Public Offering and NYSE Listing
Davis Polk advised X Financial on its SEC-registered initial public offering of 11,000,000 American Depositary Shares for an aggregate price to the public of $104.5 million. X Financial has…